Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Herbert Open Access Journals

Research

A pilot study on the use of a smartphone application to encourage emergency department patients to access preventive services: human papillomavirus vaccine as an example

Mandy J. Hill, Misha Granado, Ronald Peters, Christine Markham, Michael Ross and Richard M. Grimes*

*Correspondence: Richard M. Grimes Richard.M.Grimes@uth.tmc.edu

Author Affiliations

University of Texas Health Science Center at Houston, Medical School, 6431 Fannin, Houston Texas 77030, USA.

© 2013 Grimes et al; licensee Herbert Publications Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: In General, emergency department (ED) personnel are expert in providing episodic care and are usually too busy to attend to patients' need for preventive care. This is the case in the area of administering vaccines particularly when the vaccine protocol requires multiple injections over several months. However, ED personnel recognize the importance of patients receiving preventive services. A possible way for ED personnel to direct patients to prevention services is to use smartphone apps. A pilot study was designed to explore the possibility of using an app to foster the receipt of human papilloma virus (HPV) vaccine.

Methods: Women who met the inclusion criteria of (1) Self-identified as African-American, (2) owned a smartphone, and (3) had been cleared for discharge from the ED were recruited to a study to determine their willingness to use a smartphone app with regard to the receipt of the HPV vaccine. They completed a 30 item questionnaire that included questions about demographics, smartphone based questions, HPV knowledge based questions and perception based variables dealing with the acceptability of HPV.

Results: Nine of the 19 respondents were willing to participate in a study that would use a smartphone app dealing with HPV. Willingness to participate was significantly related to: 1) participants having health insurance and 2) comfort with HPV messages on a personal phone 3) perceived availability of the HPV vaccine and 4) comfort with an STI smartphone app on their mobile phones.

Conclusions: While there is a need for additional research in this area, this pilot study suggest the potential for using smartphones to link ED patients to preventive services. If smartphones lead to additional uptake of vaccines, there is the potential of improving the public's health in other areas of vaccine preventable diseases such as measles, mumps and rubella (MMR), Hepatitis A and B, and influenza vaccines.

Keywords: Emergency department, preventive services, vaccines, human papilloma virus

Introduction

While vaccine coverage for children is widespread, uptake of vaccines by adults in the United States is quite poor. Only about 20% of 19-64 year olds, who are considered to be at high risk, have received the pneumococcal vaccine [1]. Persons aged 18-49 years had the lowest rate of influenza vaccine uptake [2]. Similarly, only 10% of persons in this age group have had the tetanus and pertussis vaccine in the last six years. A little over a third of these individuals received all three doses of the Hepatitis B vaccine. Only one of every eight persons in this age range received both doses of the Hepatitis A vaccine. For all of these vaccines, the rate of immunizations is lower for African Americans than for Whites, Hispanics or Asians [2,3].

There is also a racial disparity in uptake of the vaccine for pathogenic human papilloma viruses (HPV) with African American women being less likely to complete the three shot series [4-12]. The HPV vaccine is recommended to be given routinely to 11-or 12-year-old girls and boys. Vaccination is also recommended for 13-through 26-year-old females and 13-through 21-year-old males who have not completed the vaccine series. The quadrivalent vaccine provides protection from HPV types 6 and 11 which cause genital warts and HPV types 16 and 18 which cause approximately 70% of cervical cancers [13]. It also prevents anal cancer, a condition that is twice as likely to occur in women than in men [14]. The vaccine has also been shown to be protective against oncogenic types of HPV in the oral cavities of women [15]. Low levels of catch-up HPV vaccine uptake by African Americans is particularly acute in 18-26 year old women with one study showing that college enrolled African American women were half as likely to be fully immunized against these strains of HPV as compared to White coeds. Other studies have shown that African American women between aged 18-26 years are less likely to initiate the catch-up vaccine than their. White counterparts [3-5,16,17]. This disparity in immunization rates has significant public health implications. Young adult, African American women have the highest rates of these pathogenic strains of HPV, and are two times more likely to develop cervical cancers related to HPV infection than their White female counterparts. They are also two times more likely to die from cervical cancer than White women [18-21].

Vaccine administration has traditionally been the province of primary care physicians as part of routine care. However, the United States is facing a growing shortage of primary care physicians which is creating access problems [22]. This shortage is particularly acute amongst minority populations and young people [23]. As a result, they seek episodic care in emergency departments (ED) which are usually far too busy dealing with acute conditions to deal with preventive measures. Still, efforts are needed to reduced missed opportunities for HPV vaccination when young adults interact with the health care system [24]. Even if emergency room providers were able to provide vaccines as part of an ED visit, there is usually no mechanism for assuring the additional injections for multi-shot vaccines for conditions like Hepatitis A, Hepatitis B and HPV.

However, ED personnel could utilize other assets that young African Americans have in order to assist them in accessing preventive services. Young African Americans are quite likely to own a mobile phone and are frequent users of applications (apps) for them. Surprisingly, 71% of those with incomes of less than $30,000 per year own a mobile phone [25]. Over 90% of persons between 18 and 29 years own a mobile phone; yet, research with this population is minimal [26]. Research findings confirm interest among young, healthy adults for apps designed to support health-related behavior change [26]. So, a potentially useful means of reaching African American women to encourage them to access preventive services is the mobile phone. The World Health Organization coined the term mobile health or mHealth for this purpose, as this technology allows the support for medical and public health practice via mobile devices [27,28]. However, there are privacy issues and concerns about receiving messages dealing with personal health issues. This is potentially a problem in dealing with sexually related issues.

This study contributes to the needed for formative research designed to better understand the interest of varied populations regarding apps and components most likely to influence acceptability, engagement, and consistent use [26]. Acceptability of using a mobile phone app to inform young African American women about a prevention issue was explored. It was decided to examine this question using the human papilloma virus vaccine as the preventive practice. If it was found acceptable for these women to use their smartphones for what is perceived as a sexually transmitted disease, it would suggest that smartphones could be a good tool for linking this population to vaccines and other preventive services.

Methods

Nineteen African American women aged 18-26 years were recruited from an emergency department (ED) of a Level I Trauma hospital. They had all sought non-emergent care. The inclusion criteria were: (1) Self-identified as African-American, (2) owned a smartphone, and (3) had been cleared for discharge from the ED. These women were approached by a research associate and were asked to participate in the study. Informed consent was obtained through the participants signing a consent form. The study was approved by the University of Texas Health Science Center at Houston's Committee for the Protection of Human Subjects, the institutional review board. Those who provided informed consent were asked to complete a 30 question survey. Respondents completed the questionnaire in a private room. The research associate stepped outside of the room to give the participant privacy, yet was accessible if the participant had any questions.

The questionnaire was based on HPV literature and included measures from published sources assessing patient's knowledge [29,30], attitudes [30], beliefs [29], potential barriers to HPV vaccination [17], and acceptability of HPV vaccinations among young adults [31]. Questions noted in the methods section of these manuscripts were modified and tailored for the study population. Additional questions concerning comfort with a smartphone and acceptability of receiving HPV messages were added.

Measures
Dependent variable
The categorical value 'perceived willingness to participate in a smartphone app based research project encouraging HPV vaccine uptake' is designated as the outcome variable for this study. The question reads, 'If given the opportunity to participate in a research project where you would get a free, interactive mobile application on your mobile phone to evaluate your willingness to get the HPV vaccine (at no cost), would you participate? The response was a yes/no format.

Independent variables
Categorical variables included demographics: age, income, education, usual source of care, existing health insurance; smart phone based questions: comfort with an STI (HPV) app on smartphone, frequency of smart phone app use, comfort with HPV messages on smartphone; HPV knowledge based questions: knowledge of HPV–transmission, prevention, vaccine requirements; perception based variables: acceptability of HPV vaccine and influence of a smart phone on HPV vaccine uptake; HPV vaccine uptake questions: actual HPV vaccine uptake.

Results

The majority of subjects recruited from the ED were 20-21 years, monthly income of $1-2K, had some college education, heterosexual orientation, utilized male condoms for contraception, had a consistent sexual partner, and reported 1 current sex partner (Table 1) of 19 participants, 47.4% were willing to use the app.

Table 1 : Demographics of study population (n=19).

A chi-square analysis of relationships between willingness to participate in a research study that used an app for the HPV vaccine show significant relationships 1) participants having health insurance and 2) comfort with HPV messages on a personal phone 3) perceived availability of the HPV vaccine and 4) comfort with an STI smartphone app on their mobile phones (Table 2).

Table 2 : Comparison of characteristics of those who were willing versus those who were unwilling to participate in a smart phone application based research project.

Discussion

Willingness to use the apps and contributing factors related to interest in apps has been assessed previously; however, few reports exist detailing developments of app based interventions for young adult, minority populations [26]. This study showed the potential for using smartphone apps as a means of directing ED patients to preventive services. Almost half of the respondents were willing to use an app that had sexual behavior overtones. It is quite likely that, if the app had been less emotionally charged, the willingness would have been higher. This is seen by the fact that the question dealing with willingness to participate was strongly influenced by the respondents' willingness to have an app that dealt with what was perceived to be a sexually transmitted infection. This finding is supported by the literature, as young adults viewed health apps as slightly embarrassing and being seen using one appeared socially undesirable [26].

Other potentially mediating factors influencing comfort with an HPV vaccine application on a smartphone include 1) culture, 2) caution about research and 3) vaccine history. Reports suggest that smartphone ownership not only involves our way of communicating but also augments our sense of culture, community, identity, and relationships [32,33]. African Americans routinely note a culture of mistrust of the health care system, which contributes to barriers to health care access and routine vaccine uptake [2]. Comfort with HPV messages on a personal smartphone may reflect cultural acceptance in accessing related sensitive prevention services, including contraception, STI prevention, and HIV testing. An additional confounder with regard to participation was related to the dependent variable's use of the term "research." The unethical practices experienced by African Americans in the infamous Tuskegee Experiment lead them to be cautious of participating research projects [34]. Vaccine history is a known predictor of willingness to initiate and complete the HPV vaccine among women aged 18-26 years [35]. Study findings revealed 56% of women who initiated the HPV vaccine completed it and regression analysis found completion rates to be linked with a history of obtaining the influenza vaccine and lifetime vaccines [10,35]. Smartphones potentially provide an ideal medium for interventions encouraging uptake of vaccines.

Although over 40,000 apps that address prevention and care exist [27], their effectiveness as a delivery channel has not been well established. This pilot study suggests that there is real potential for developing apps in other preventive areas. HPV vaccination may be the most difficulty vaccine today to acquire societal buy-in. Barriers to vaccine uptake include concern about vaccine safety [10,36,37] and health insurance [16,38]. Research has shown that uptake and completion of the HPV vaccine is poor among people of the African American race [16,35,39-42], and those with an uninsured status uninsured status [35], and low income. Although barriers to vaccine uptake are well documented in the literature, particularly among African American females, our study population reported willingness to receive the vaccine when people perceived the vaccine as available at no cost. Reported facilitators of HPV vaccine uptake are knowledge of HPV vaccine [43], higher perceived severity of HPV infection [43-45], and having private health insurance [46,47]. Facilitators for both uptake and series completion include unmarried status [35], vaccine history [35,44,46], and subjective norms endorsing HPV vaccination uptake [42,44,47-49].

Limitations
The primary limitation of the study is the small sample size. Clearly this pilot study needs to be replicated with a larger sample size and at other EDs. Another study limitation is that the data was based on self-report. Additional survey questions assessing comfort with using smartphones for prevention apps and acceptability have not been validated. Inherent limitations of the inclusion criteria, related to age and gender, may have impacted participant willingness, or the lack thereof, regarding use of an app on their smartphone.

Conclusions

While there is a need for additional research in this area, this pilot study suggest young adults are willing to download an app on their smartphone with messages about STIs, substantiating the potential for using smartphones to link ED patients to preventive services. If smartphones lead to additional uptake of vaccines, there is the potential of improving the public's health in other areas of vaccine preventable diseases such as measles, mumps and rubella (MMR), Hepatitis A and B, and influenza vaccines.

Future research

The majority of healthcare apps available today are simple and provide basic information [27], which likely contributes to many apps having few downloads and inconsistent use[27]. Gaining and sustaining the interest of app users is a key component to the success of mobile health interventions. A previous study reported participants found apps that integrate well with the way they used their smartphones naturally were most appealing and useful [26]. Findings support two key components in app development: 1) ease of use and 2) appealing features. The way users choose to use or discontinue use of apps on their phones reflect these two components [26]. An app promoting HPV vaccine uptake and series completion should inform vaccine eligible women about the vaccine, guide them towards series completion, remind/alert them when the next date of vaccination approaches, and communicate with them consistently regarding the vaccine and the importance of series completion [27]. An app encompassing all of these components, while aligning with the natural use of the phone, has a sound likelihood of success.

Future academicians, ED clinicians and other health care providers with an interest in app development should explore the following variables: age, gender, user expectation of ntertainment/engagement, user expectation of high 'production values', health behavior modification through 'gaming', and related costs (i.e., development, maintenance, and marketing). Consideration of these elements of app development is critical to acceptance of mobile health interventions designed to engage young adults into their own healthy behavioral changes.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Authors' contributions MJH MG RP CM MR RMG
Research concept and design --
Collection and/or assembly of data -- -- --
Data analysis and interpretation -- -- --
Writing the article -- -- -- --
Critical revision of the article -- -- -- --
Final approval of article -- -- -- --
Statistical analysis -- -- -- -- --

Acknowledgement

This publication was made possible with help from the Baylor-UTHouston Center for AIDS Research (CFAR), an NIH funded program (AI036211).

Publication history

EIC: Joseph Varon, University Of Texas Medical Branch, USA.
Received: 01-Nov-2013 Revised: 08-Dec-2013
Accepted: 12-Dec-2013 Published: 19-Dec-2013

References

  1. Immunization Action Coalition. Ask the Experts. Pneumococcal Vaccines (PCV13 and PPSC23). 2013. | Article
  2. Ford K, Meshack A, Roberts M, Amos C, Rhodes W, Barkley L and Peters R. H1N1 Vaccination Uptake Among African American College Students. American Journal of Health Studies. 2012; 27:129-135. | Article
  3. Noninfluenza vaccination coverage among adults-United States, 2011. MMWR Morb Mortal Wkly Rep. 2013; 62:66-72. | Article | PubMed
  4. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA and Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011; 127:77-84. | Article | PubMed Abstract | PubMed Full Text
  5. Chao C, Velicer C, Slezak JM and Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010; 171:357-67. | Article | PubMed Abstract | PubMed Full Text
  6. National, state, and local area vaccination coverage among adolescents aged 13-17 years --- United States, 2009. MMWR Morb Mortal Wkly Rep. 2010; 59:1018-23. | Article | PubMed
  7. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011. MMWR Morb Mortal Wkly Rep. 2012; 61:671-7. | Article | PubMed
  8. Dorell CG, Yankey D, Santibanez TA and Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011; 128:830-9. | Article | PubMed
  9. Kester LM, Zimet GD, Fortenberry JD, Kahn JA and Shew ML. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J. 2013; 17:879-85. | Article | PubMed
  10. Perkins RB, Brogly SB, Adams WG and Freund KM. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study. J Womens Health (Larchmt). 2012; 21:813-20. | Article | PubMed Abstract | PubMed Full Text
  11. Schluterman NH, Terplan M, Lydecker AD and Tracy JK. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine. 2011; 29:3767-72. | Article | PubMed
  12. Tan W, Viera AJ, Rowe-West B, Grimshaw A, Quinn B and Walter EB. The HPV vaccine: are dosing recommendations being followed? Vaccine. 2011; 29:2548-54. | Article | PubMed
  13. Centers for Disease Control and Prevention. HPV Vaccine Information for Clinicians-Fact Sheet. 2012 | Article
  14. Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012; 61:258-61. | Article | PubMed
  15. Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S and Kreimer AR. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013; 8:e68329. | Article | PubMed Abstract | PubMed Full Text
  16. Dempsey A, Cohn L, Dalton V and Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine. 2011; 29:528-34. | Article | PubMed Abstract | PubMed Full Text
  17. Bednarczyk RA, Birkhead GS, Morse DL, Doleyres H and McNutt LA. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine. 2011; 29:3138-43. | Article | PubMed
  18. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS and Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA. 2007; 297:813-9. | Article | PubMed
  19. Horner M.J, Ries L.A., Krapcho M, Neyman N and  Aminou R. SEER Cancer Statistics Review, 1975-2006. National Cancer Institute. | Website
  20. Pickle LW, Hao Y, Jemal A, Zou Z, Tiwari RC, Ward E, Hachey M, Howe HL and Feuer EJ. A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin. 2007; 57:30-42. | Article | PubMed
  21. Center for Disease Control and Prevention/National Center for Health Statistics. 2010. | Webiste
  22. Cross, M.A. What the primary care shortage means for health plans. M.Care. Editor. 2007. | Article
  23. Commonwealth Fund. When minority patients have insurance and a medical home, their health care improves, says new survey.| Website
  24. Holman DM, Benard V, Roland KB, Watson M, Liddon N and Stokley S. Barriers to Human Papillomavirus Vaccination Among US Adolescents: A Systematic Review of the Literature. JAMA Pediatr. 2013. | Article | PubMed
  25. Mindel A, McHugh L, Christie E, Chung C and Berger T. Genital herpes: an Internet-based risk survey. Int J STD AIDS. 2009; 20:785-9. | Article | PubMed
  26. Dennison L, Morrison L, Conway G and Yardley L. Opportunities and challenges for smartphone applications in supporting health behavior change: qualitative study. J Med Internet Res. 2013; 15:e86. | Article | PubMed Abstract | PubMed Full Text
  27. IMS Institute for Healthcare Informatics. Patient Apps for Improved Healthcare: From Novelty to Mainstream. 2013, IMS Institute for Healtcare Informatics: Parsippany, NJ.  60. | Pdf
  28. Global Observatory for eHealth series, mHealth: New horizons for health through mobile technologies. 2011. | Website
  29. Gerend MA and Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health. 2008; 42:237-42. | Article | PubMed
  30. Narouz N, Allan PS and Wade AH. Genital herpes: general practitioners' knowledge and opinions. Sex Transm Infect. 2002; 78:198-200. | Article | PubMed Abstract | PubMed Full Text
  31. Sundstrom K, Tran TN, Lundholm C, Young C, Sparen P and Dahlstrom LA. Acceptability of HPV vaccination among young adults aged 18-30 years--a population based survey in Sweden. Vaccine. 2010; 28:7492-500. | Article | PubMed
  32. Boulos M.N et al. How smartphones are changing the face of mobile and participatory healthcare: an overview, with example from eCAALYX. Biomed Eng Online. 2011; 10: 24. | Article
  33. Traxler J. Mobile Subcultures, in Connected minds, emerging cultures: Cybercultures in online learning. S.Wheeler. Editor. 2008: Charlotte, NC. p. 17-28. | Article
  34. Hill M, Meshack A, Ford K, Amos C, Rhodes W, Barkley L and Peters R.  A Gender Analysis of H1N1 Vaccine Uptake Acceptability among African American Students Attending a Historically Black College or University. Journal of Research Association for Minority Professors. 2011; 14:72-81. | Website
  35. Laz TH, Rahman M and Berenson AB. Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer. 2013; 119:1386-92. | Article | PubMed
  36. Perkins RB, Pierre-Joseph N, Marquez C, Iloka S and Clark JA. Parents' opinions of mandatory human papillomavirus vaccination: does ethnicity matter? Womens Health Issues. 2010; 20:420-6. | Article | PubMed Abstract | PubMed Full Text
  37. Printz C. HPV vaccine uptake remains low. Why some adolescents are not receiving the vaccine, and what can be done about it. Cancer. 2013; 119:2947-8. | Article | PubMed
  38. Dempsey AF, Schaffer SE and Cohn LM. Follow-up analysis of adolescents partially vaccinated against human papillomavirus. J Adolesc Health. 2012; 50:421-3. | Article | PubMed
  39. Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R and Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012; 30:3546-56. | Article | PubMed
  40. Licht AS, Murphy JM, Hyland AJ, Fix BV, Hawk LW and Mahoney MC. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sex Transm Infect. 2010; 86:74-8. | Article | PubMed
  41. Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K and Hickman M. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol. 2013; 42:896-908. | Article | PubMed Abstract | PubMed Full Text
  42. Polonijo AN and Carpiano RM. Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory. Soc Sci Med. 2013; 82:115-25. | Article | PubMed
  43. Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM and Singhal R. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomarkers Prev. 2011; 20:1463-72. | Article | PubMed Abstract | PubMed Full Text
  44. de Visser R, Waites L, Parikh C and Lawrie A. The importance of social norms for uptake of catch-up human papillomavirus vaccination in young women. Sex Health. 2011; 8:330-7. | Article | PubMed
  45. Ferris DG, Waller JL, Owen A and Smith J. HPV vaccine acceptance among mid-adult women. J Am Board Fam Med. 2008; 21:31-7. | Article | PubMed
  46. Anhang Price R, Tiro JA, Saraiya M, Meissner H and Breen N. Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer. 2011; 117:5560-8. | Article | PubMed Abstract | PubMed Full Text
  47. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S and Kahn JA. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt). 2009; 18:1679-86. | Article | PubMed
  48. Marchand E, Glenn BA and Bastani R. Low HPV vaccine coverage among female community college students. J Community Health. 2012; 37:1136-44. | Article | PubMed Abstract | PubMed Full Text
  49. Allen JD, Mohllajee AP, Shelton RC, Othus MK, Fontenot HB and Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med. 2009; 48:420-5. | Article | PubMed
ISSN 2052-6229
Volume 1
Full text Download
Citation

Get Citation

Hill MJ, Granado M, Peters R, Markham C, Ross M and Grimes RM. A pilot study on the use of a smartphone application to encourage emergency department patients to access preventive services: human papillomavirus vaccine as an example. Emerg Med Health Care. 2013; 1:4. http://dx.doi.org/10.7243/2052-6229-1-4

Download citation file:

close
share


Order Reprints

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player